Autism Impact Fund

AIF is a healthcare fund focused on the growing mental health market with a particular emphasis on innovation in ASD (“Autism Spectrum Disorder”) and related conditions (ADD, ADHD, Social Anxiety, GI, etc.). We target market VC returns and invest in scalable businesses that create a better world for individuals with ASD, neurodevelopmental disorders, mental health issues, and other complex chronic conditions. In the U.S. alone, 5.4 million individuals have received an ASD diagnosis, 11 million children have a NDD, and 66 million individuals have a mental health condition. For reasons that are not entirely understood, the prevalence of these conditions is increasing exponentially, with no signs of slowing down. Of note, ASD prevalence has increased by 241% over the past two decades. At AIF, we are tapping a ~$800 billion market, directing capital toward companies that are transforming how ASD, NDDs, mental health issues, and other complex chronic conditions are diagnosed, treated, and managed. By investing in innovative life sciences and tech- and data-enabled services companies, we are using venture capital investment as a vehicle for deepening understanding, establishing a better standard of care, and enabling the individuals (and their families) affected by these conditions to reach their full potential